etherna

Today, on 𝗪𝗼𝗿𝗹𝗱 𝗣𝗮𝘁𝗶𝗲𝗻𝘁 𝗦𝗮𝗳𝗲𝘁𝘆 𝗗𝗮𝘆, we join the global community in reflecting on an essential truth: 𝗲𝗮𝗰𝗵 𝗼𝗳 𝘂𝘀 𝗰𝗼𝘂𝗹𝗱 𝗯𝗲 𝗮 𝗽𝗮𝘁𝗶𝗲𝗻𝘁 𝗼𝗻𝗲 𝗱𝗮𝘆. We all deserve the safest, most effective care possible. We are proud to contribute to the future of healthcare by enabling breakthrough nucleic acid-based medicines through our innovative RNA and customized LNPs. 𝗢𝘂𝗿 𝗺𝗶𝘀𝘀𝗶𝗼𝗻 𝗶𝘀 to empower our partners to create new therapeutics that treat diseases and do so safely, 𝗶𝗺𝗽𝗿𝗼𝘃𝗶𝗻𝗴 𝘁𝗵𝗲 𝗾𝘂𝗮𝗹𝗶𝘁𝘆 𝗼𝗳 𝗹𝗶𝗳𝗲 𝗳𝗼𝗿 𝗰𝗼𝘂𝗻𝘁𝗹𝗲𝘀𝘀 𝗽𝗮𝘁𝗶𝗲𝗻𝘁𝘀. World Patient Safety Day organized by the World Health Organization (WHO), reminds us that patients must be at the heart of everything we do and everything we do would be 𝗶𝗺𝗽𝗼𝘀𝘀𝗶𝗯𝗹𝗲 𝘄𝗶𝘁𝗵𝗼𝘂𝘁 𝗼𝘂𝗿 𝘁𝗲𝗮𝗺 𝗼𝗳 𝗲𝘅𝗽𝗲𝗿𝘁𝘀. They are committed to guaranteeing the highest standards of patient safety: ✔️𝗖𝘂𝘁𝘁𝗶𝗻𝗴-𝗲𝗱𝗴𝗲 𝗥&𝗗 From discovery concepts, over preclinical and translational studies up to clinical trials, our R&D teams continuously push the boundaries of science to ensure that every therapeutic we help develop meets the strictest safety standards. ✔️𝗨𝗻𝗰𝗼𝗺𝗽𝗿𝗼𝗺𝗶𝘇𝗶𝗻𝗴 𝗾𝘂𝗮𝗹𝗶𝘁𝘆 Our experts work tirelessly to build in quality from the start and maintain the highest purity and precision in every batch, ensuring the safety and efficacy of future treatments. ✔️𝗖𝘂𝘀𝘁𝗼𝗺𝗶𝘇𝗲𝗱 𝘀𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝘀 𝗳𝗼𝗿 𝘀𝗮𝗳𝗲 𝘁𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰𝘀 Our tailored RNA-LNP solutions are designed to deliver safely, maximizing therapeutic potential while minimizing the risk. Patient safety is at the core of what we do, and 𝗼𝘂𝗿 𝗲𝘅𝗽𝗲𝗿𝘁𝘀 𝗽𝗹𝗮𝘆 𝗮 𝗽𝗮𝗿𝘁 𝗶𝗻 𝗱𝗿𝗶𝘃𝗶𝗻𝗴 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝘁𝗵𝗮𝘁 𝗽𝘂𝘁𝘀 𝗽𝗲𝗼𝗽𝗹𝗲 𝗳𝗶𝗿𝘀𝘁 𝘀𝗼 𝘁𝗼𝗱𝗮𝘆 𝘄𝗲 𝘄𝗮𝗻𝘁 𝘁𝗼 𝘁𝗵𝗮𝗻𝗸 𝗮𝗹𝗹 𝗼𝗳 𝘁𝗵𝗲𝗺. Let's continue to innovate, collaborate, and prioritize safety for a healthier tomorrow! #WorldPatientSafetyDay #HealthcareInnovation #mRNA #LNPs #PatientFirst #WHO #teamwork

Gain insights into the latest advancements in achieving 𝗾𝘂𝗮𝗹𝗶𝘁𝘆 𝗥𝗡𝗔 & 𝗟𝗡𝗣 𝘁𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰𝘀! Our Senior VP Manufacturing, Phil Challis, who was presenting on RNA Leaders last week, shares his insights with you. Don't miss out on this resource when you are looking to stay at the forefront of RNA and LNP science. Here are 𝟯 𝘁𝗮𝗸𝗲𝗮𝘄𝗮𝘆𝘀: 1️⃣ Optimized 𝗨𝗧𝗥𝘀 𝗳𝗼𝗿 𝗲𝗻𝗵𝗮𝗻𝗰𝗲𝗱 𝘀𝘁𝗮𝗯𝗶𝗹𝗶𝘁𝘆 and translation 2️⃣ Advanced mRNA production processes ensuring 𝗵𝗶𝗴𝗵 𝗽𝘂𝗿𝗶𝘁𝘆 3️⃣ Innovative ionizable lipids for 𝘀𝘂𝗽𝗲𝗿𝗶𝗼𝗿 𝗟𝗡𝗣 𝗱𝗲𝗹𝗶𝘃𝗲𝗿𝘆 systems Download your copy now and explore how cutting-edge solutions are shaping the future of RNA-based therapies! 👉https://lnkd.in/e-Je25tR

Yesterday, we had the pleasure of welcoming Bert Poedts to our team! Bert joins our team in Ghent as Research Associate Drug Product Development. He is eager to roll up his sleeves and put his impressive lab skills to work. We can't wait to see the amazing contributions he will bring to our mission! Let's do great things together, Bert! #NewTeamMember #Welcome #RNA #LNP

𝗗𝗮𝘆 𝟮 𝗮𝘁 𝗥𝗡𝗔 𝗟𝗲𝗮𝗱𝗲𝗿𝘀 𝗨𝗦! Our team, Phil Challis, Shelly West, and Bram Bogaert is still going strong RNA Leaders! Today, we were excited to have our very own Senior VP Manufacturing, Phil Challis, present on quality in RNA & LNP therapeutics and how to achieve this in practice. If you haven't stopped by our booth (booth #26), don't wait. Day 2 is also the final day to meet our team and discuss the future of RNA & LNP therapeutics. And yes, we still have some delicious Belgian chocolates to share. 🍫😉 Be sure to catch Phil, Shelly, or Bram before it's over! #RNALeadersUS #RNAQuality #Therapeutics #LNP

September… the start of a new school year and a fresh chapter for all the budding scientists out there! Buzzing classrooms and labs reminds us of the passion, curiosity, and drive that makes our industry thrive.   To all graduate students who are no longer starting a new school year but a new journey as scientists: whether you are perfecting your pipette skills, decoding the mysteries of DNA, deep diving into RNA research, or exploring the world of lipid nanoparticles, know that your future is bright.   We are always on the lookout for talented people ready to make a real impact. Let's connect and explore how we can shape the future of RNA and LNP therapeutics together! https://lnkd.in/dzEnyZd #BackToSchool #BiotechCareers #RNAResearch #LNP

This week we were pleased to welcome Gwenda as our latest team member! Gwenda is our new 𝗢𝗳𝗳𝗶𝗰𝗲 𝗖𝗼𝗼𝗿𝗱𝗶𝗻𝗮𝘁𝗼𝗿 and from handling our incoming goods to ensuring there is always coffee and the cookie jar is never empty, Gwenda is here to make sure our office runs smoother than ever. With her on board, you can bet 𝗼𝘂𝗿 𝗼𝗳𝗳𝗶𝗰𝗲 𝗶𝘀 𝗶𝗻 𝗲𝘅𝗰𝗲𝗹𝗹𝗲𝗻𝘁 𝗵𝗮𝗻𝗱𝘀. Welcome aboard, Gwenda! Join us in giving Gwenda a warm welcome! PS. Our favorite cookie is Biscoff with Chocolate by Lotus Bakeries! What's your favorite? 🍪😊

We are heading to 𝗥𝗡𝗔 𝗟𝗲𝗮𝗱𝗲𝗿𝘀 𝗨𝗦 in San Diego on September 4-5! We’re excited to join this leading event with our colleagues Phil Challis, Bram Bogaert, and Shelly West, where experts will be sharing the latest advancements in RNA therapeutics. Our SVP Manufacturing, Phil Challis, will be presenting insights on ensuring the quality of your RNA and LNP therapeutics – and how to apply them in practice. Don’t miss it out! 📅 September 5 ⏱ 10:20 am We’re looking forward to connecting with fellow researchers, scientists, and industry leaders. Let’s continue pushing the boundaries of science together! Come and see us at 𝗯𝗼𝗼𝘁𝗵 𝟮𝟲! Thank you, RNA Leaders for the smooth organization! #RNATherapeutics #RNAleaders #LNP #Science #SanDiego

How can you reduce the cost of your RNA-LNP therapeutics? When it comes to RNA-LNP therapeutics, cost reduction isn't just about saving on materials or improving process efficiency - it's about strategic planning from day one. Here are the key strategies you should be focusing on: 🧪 Optimize RNA chemistry 📈 Ionizable lipid and LNP design ⚙ Process technologies 💡 Material cost management Click below to read more about these 4 key strategies. Any questions? We can help you apply these strategies to ensure that your RNA-LNP therapeutics remain cost-efficient while delivering high-quality results. #RNATherapeutics #CostReduction #BioTech #LNP #ProcessOptimization

𝗖𝗲𝗹𝗲𝗯𝗿𝗮𝘁𝗶𝗻𝗴 𝟱 𝘆𝗲𝗮𝗿𝘀 𝗼𝗳 𝗴𝗿𝗼𝘄𝘁𝗵, 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻, 𝗮𝗻𝗱 𝘁𝗲𝗮𝗺 𝘀𝗽𝗶𝗿𝗶𝘁! Yesterday, we raised a toast to two incredible colleagues who greatly impacted our pharmacology team. Summarizing 5 years is impossible so we want to thank Lotte and Elisabeth. We look forward to what may come. 🥼Elisabeth Brabants: From a non-clinical scientist to a leading in vitro pharmacology scientist, Elisabeth's journey is a testimony of her passion for science, relentless curiosity, and positivity. Her expertise has been vital in advancing our research and driving forward our innovative projects. 🔬Lotte Jacobs: She started as a Research Associate and is now our go-to Senior Research Associate. Her dedication and meticulous work have helped us achieve key milestones. Her enthusiasm is indispensable within the team. Lotte, Elisabeth, and the team enjoyed some delicious cake because every great achievement deserves a celebration! Thanks, Bakkerij Aernoudt for the delicious and personalized cake! #workanniversary #teamsuccess #mRNA

𝗘𝗻𝗵𝗮𝗻𝗰𝗲 𝘆𝗼𝘂𝗿 𝗺𝗥𝗡𝗔 𝗾𝘂𝗮𝗹𝗶𝘁𝘆: 𝗮𝗰𝗰𝗲𝘀𝘀 𝗼𝘂𝗿 𝗹𝗮𝘁𝗲𝘀𝘁 𝘄𝗵𝗶𝘁𝗲𝗽𝗮𝗽𝗲𝗿𝘀   Since March we launched 4 new whitepapers with the main focus on improving the quality of mRNA and they are still available for free download on our website. Our team of experts, with over 30 years of experience in RNA technology, has poured their expertise into these papers, 𝗼𝗳𝗳𝗲𝗿𝗶𝗻𝗴 𝘆𝗼𝘂 𝗳𝗿𝗲𝘀𝗵 𝗽𝗲𝗿𝘀𝗽𝗲𝗰𝘁𝗶𝘃𝗲𝘀 𝗮𝗻𝗱 𝗮𝗱𝘃𝗮𝗻𝗰𝗲𝗱 𝗺𝗲𝘁𝗵𝗼𝗱𝗼𝗹𝗼𝗴𝗶𝗲𝘀 in:   🥼Utilizing 𝗡𝗲𝘅𝘁-𝗚𝗲𝗻𝗲𝗿𝗮𝘁𝗶𝗼𝗻 and 𝗧𝗵𝗶𝗿𝗱-𝗚𝗲𝗻𝗲𝗿𝗮𝘁𝗶𝗼𝗻 𝗦𝗲𝗾𝘂𝗲𝗻𝗰𝗶𝗻𝗴 for RNA Quality Attribute Monitoring by Anna-Marei Böhm 🥼 Why 𝗺𝘂𝗹𝘁𝗶𝗳𝗮𝗰𝗲𝘁𝗲𝗱 𝗽𝗵𝘆𝘀𝗶𝗰𝗼𝗰𝗵𝗲𝗺𝗶𝗰𝗮𝗹 𝗰𝗵𝗮𝗿𝗮𝗰𝘁𝗲𝗿𝗶𝘇𝗮𝘁𝗶𝗼𝗻 is key to ensure the stability of your mRNA-LNP drug product by Sarah Vandenberghe 🥼Improving mRNA Quality by 𝗥𝗲𝗺𝗼𝘃𝗮𝗹 𝗼𝗳 𝗧𝗿𝘂𝗻𝗰𝗮𝘁𝗲𝗱 𝗺𝗥𝗡𝗔 𝗦𝗽𝗲𝗰𝗶𝗲𝘀 by Oligodt Purification by Mateusz Kozarski 🥼 Strengthening 𝗖𝗼𝗻𝘁𝗿𝗼𝗹 𝗼𝗳 𝗗𝗼𝘂𝗯𝗹𝗲-𝗦𝘁𝗿𝗮𝗻𝗱𝗲𝗱 𝗥𝗡𝗔 in mRNA Manufacturing Processes by Senne Dillen   Whether you're in a start-up, early-stage, or late-stage project, our proprietary platforms can support your journey in RNA therapeutics. Dive into our latest research and discover how we can help drive your pipeline development or resolve manufacturing challenges.   Click below to download your copies now and stay ahead in the ever-evolving field of RNA therapeutics! 👉 https://lnkd.in/eyaS-f34